Apneic Oxygénation by Nasal Canula During Infants Airway Management Study
NCT ID: NCT03967769
Last Updated: 2020-07-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
72 participants
INTERVENTIONAL
2019-08-05
2020-11-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Apnoeic Oxygenation During Pediatric Tracheal Intubation
NCT06576596
Optimizing High Flow Nasal Cannula Oxygenation in Pediatric Airway Procedures
NCT06947902
Effectiveness Of Apneic Oxygenation During Induction Of General Anesthesia In Children
NCT06742476
Interest of High Flow Nasal Cannula Oxygen Therapy in Pediatric Intensive Care Unit
NCT03505814
Automation Oxygen Flow Titration in Spontaneously Breathing Infants
NCT03614507
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This is a randomized clinical trial investigating the utility of apneic oxygenation via high flow nasal cannula during airway management for infant's general anesthesia. Three groups will be compared, a control group at 0 L/min, a 0,2L/Kg/min and a 1L/Kg/min group. The primary outcome will be the time (in seconds) between onset of apnea and one of these end-points : desaturation (SPO2 \<95%) or Airway management completed.
All infants included will receive french actual standard of care concerning general anesthesia and peri-operative medicine.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
All participants will receive French actual standard of care of surgery and anesthesia.
PREVENTION
TRIPLE
Finally, the independent trial statistician and the members of the data monitoring and safety committee (DMSC) will also remain blinded for the allocation during analysis.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard Practice
Infants will have high Flow nasal cannulae placed into the nares before induction. They will be removed from the nares at the end of the study when the airway has been secured. There will be no oxygen flowing through the cannulae in this group during the study.
No interventions assigned to this group
Low Flow oxygenation
Infants will have conventional nasal cannulae into the nares prior to induction of anesthesia. They will be removed from the nares at the end of the study when the airway has been secured. There will be 0,2L/kg/min of oxygen flowing through the cannulae in this group during the study.
High Flow nasal Cannula
Apnoeic Oxygenation by High Flow Nasal Cannulae
High Flow Oxygenation
Infants will have conventional nasal cannulae into the nares prior to induction of anesthesia. They will be removed from the nares at the end of the study when the airway has been secured. There will be 1L/kg/min of oxygen flowing through the cannulae in this group during the study.
High Flow nasal Cannula
Apnoeic Oxygenation by High Flow Nasal Cannulae
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High Flow nasal Cannula
Apnoeic Oxygenation by High Flow Nasal Cannulae
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled for elective surgery under general anesthesia
* Need of orotracheal Intubation by direct laryngoscopy or Video-laryngoscopy
Exclusion Criteria
* Crush Induction needed
* High clinical risk of difficult airway management
* Premature before 1 month of life
24 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Clermont-Ferrand
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Adeline Gerst
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Clermont-Ferrand
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU
Clermont-Ferrand, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Adeline Gerst
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-004127-36
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
Oxyneo
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.